Want to see DGX full AI Analyst Report?
Revenue by Segment
Shows the revenue contribution from each business segment, indicating which areas are the most lucrative and where the company might focus future growth efforts.
DIS is the clear growth engine—recent quarters show re-acceleration driven by strong volume wins and new diagnostic/commercial rollouts, which prompted management to raise 2026 guidance. That momentum masks a mix shift: large client ramps are boosting volumes but lower revenue-per-requisition and contributed to near-term margin pressure. DS remains flat and immaterial to growth. Key risks to monitor: heavier H2 Project Nova spend, higher fuel costs, reimbursement (PAMA/ACA) uncertainty, and rising DSO affecting cash conversion.
DGX Revenue by Segment
| Date | DIS | DS |
|---|---|---|
| Sep 30, 2026 | $3.04B | $62.00M |
| Jun 30, 2026 | $2.98B | $65.00M |
| Mar 31, 2026 | $2.83B | $63.00M |
| Dec 31, 2025 | $2.74B | $64.00M |
| Sep 30, 2025 | $2.75B | $61.00M |
| Jun 30, 2025 | $2.70B | $62.00M |
| Mar 31, 2025 | $2.59B | $63.00M |
| Dec 31, 2024 | $2.56B | $65.00M |
| Sep 30, 2024 | $2.43B | $61.00M |
| Jun 30, 2024 | $2.33B | $64.00M |
| Mar 31, 2024 | $2.30B | $68.00M |
| Dec 31, 2023 | $2.22B | $67.00M |
| Sep 30, 2023 | $2.23B | $67.00M |
| Jun 30, 2023 | $2.27B | $70.00M |
| Mar 31, 2023 | $2.26B | $72.00M |
| Dec 31, 2022 | $2.27B | $68.00M |
| Sep 30, 2022 | $2.42B | $67.00M |
| Jun 30, 2022 | $2.38B | $69.00M |
| Mar 31, 2022 | $2.54B | $70.00M |
| Dec 31, 2021 | $2.67B | $70.00M |
| Sep 30, 2021 | $2.70B | $71.00M |
| Jun 30, 2021 | $2.47B | $76.00M |
| Mar 31, 2021 | $2.64B | $77.00M |
| Dec 31, 2020 | $2.92B | $80.00M |
| Sep 30, 2020 | $2.71B | $77.00M |
| Jun 30, 2020 | $1.76B | $63.00M |
| Mar 31, 2020 | $1.74B | $78.00M |